Press Releases

Première biopsie liquide à recevoir l’approbation de la FDA pour le profilage complet des tumeurs dans tous les cancers solides, le diagnostic compagnon Guardant360® de Guardant Health gagne en crédibilité auprès des oncologues en Asie, au Moyen-Orient et en Afrique.

SINGAPOUR, 8 août 2020 /PRNewswire/ — La Food and Drug Administration (FDA) des États-Unis a approuvé la biopsie liquide de Guardant Health, le diagnostic compagnon Guardant360®, pour le profilage des mutations tumorales chez les patients atteints de toutes sortes de cancers solides. Pour Guardant Health Asia, Middle East and Africa (AMEA), cette approbation de la FDA […]


Humanitarian Affairs Minister seeks better collaboration with the Media

The Minister of Humanitarian Affairs, Disaster Management and Social Development, Sadiya Umar Farouq has called for more collaboration with the media for a robust dissemination of information on humanitarian issues. The Minister stated this while receiving in audience a delegation of the National and Abuja EXCO members of the Nigerian Union of Journalists (NUJ), led […]


Nigeria partners with UK to host Telecomms conference

The government of the United Kingdom and Greenfields Law is to  partner with the Nigerian Federal Ministry of Communications and Digital Economy and Nigerian Communications Commission ,NCC, to host  National Technical Conference on Right of Way(RoW) and Site Build Permitting. The Technical Conference is part of the UK Government’s Technical Assistance package in advancing policy […]

Press Releases

First liquid biopsy to receive FDA Approval for comprehensive tumor profiling across all solid cancers, Guardant Health’s Guardant360® CDx, gains credibility among oncologists in Asia, Middle East and Africa.

SINGAPORE, Aug. 8, 2020 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Guardant Health’s liquid biopsy, Guardant360® CDx, for tumor mutation profiling in patients across all solid cancers. For Guardant Health Asia, Middle East and Africa (AMEA), this FDA approval represents a landmark achievement for the Guardant360 test. Currently, the liquid biopsy is […]